Skip to main content
. 2020 Oct 19;2020(10):CD012859. doi: 10.1002/14651858.CD012859.pub2

de Morais 2018.

Methods Randomized controlled trial
Participants Patients scheduled for laparoscopic procedures to treat abdominal or pelvic cancer, 18 to 70 years of age, ASA status I or II, Apfel score of 3 or 4
Interventions Oral starch (control group) or 80 mg oral aprepitant (treatment group) 1 hour before induction
Outcomes PONV, adverse effects
Notes Study identified after the first search; data will be included in next update of the review